UroGen Pharma Ltd. (URGN)
24.87
+2.33
(+10.34%)
USD |
NASDAQ |
Apr 20, 16:00
25.00
+0.13
(+0.52%)
After-Hours: 20:00
UroGen Pharma Shareholders Equity (Quarterly) : -105.47M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | 1.007B |
| Cogent Biosciences, Inc. | 636.37M |
| Puma Biotechnology, Inc. | 130.34M |
| Zymeworks, Inc. | 268.50M |
| Xeris Biopharma Holdings, Inc. | 13.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.46M |
| Total Liabilities (Quarterly) | 305.93M |
| Debt to Equity Ratio | -1.233 |
| Current Ratio | 4.008 |
| Net Debt Paydown Yield | -0.13% |